ACR24 - Day1b

Dive into the latest on rheumatic diseases, starting with the fast-acting benefits of JAK inhibitors compared to TNF inhibitors. Discover paroxynase-1 as a potential predictor for arthritis progression. Weight loss drugs are making waves in psoriatic arthritis treatment, but is their effect sustainable? Explore how gender influences disease activity measures, and learn about upadacitinib's success in treating giant cell arteritis while tackling the complexities of CAR-T therapies. It's a treasure trove of insights!